Depth of Response and Progression-Free Survival in CLL Patients on Ibrutinib

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2018年 / 16卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [41] MPT improves progression-free survival in elderly patients with multiple myeloma
    不详
    Nature Clinical Practice Oncology, 2009, 6 (1): : 4 - 4
  • [42] A Proposal for Progression-Free Survival Assessment in Patients with Early Progressive Cancer
    Tanase, Takanori
    Hamada, Chikuma
    Yoshino, Takayuki
    Ohtsu, Atsushi
    ANTICANCER RESEARCH, 2017, 37 (10) : 5851 - 5855
  • [43] NSCLC: Pembrolizumab improves progression-free survival
    Simon, Annika
    PNEUMOLOGIE, 2023, 77 (04):
  • [44] IS PROGRESSION-FREE SURVIVAL A GOOD INDICATOR OF OVERALL SURVIVAL FOR PAZOPANIB IN PATIENTS WITH SYNOVIAL SARCOMA?
    Han, J.
    Lee, S.
    Cho, E.
    VALUE IN HEALTH, 2022, 25 (12) : S489 - S490
  • [45] Survival and progression-free survival in patients undergoing curative resection for intrahepatic cholangiocarcinoma.
    Ozturk, Nazli Begum
    Jamil, Laith H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 562 - 562
  • [46] Development of a nomogram to predict the progression-free survival in lung cancer patients
    Tafenzi, H. A.
    Choulli, F.
    Baladi, A.
    El Fadli, M.
    Essadi, I.
    Belbaraka, R.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S155 - S155
  • [47] KI-67 IS ASSOCIATED WITH PROGRESSION-FREE SURVIVAL IN PATIENTS WITH GLIOBLASTOMA
    Bergman, Drew
    Anand, Sumyuktha
    Gill, Gobind
    Harris, Brent
    Fadul, Camilo
    Havrda, Matthew
    Pointer, Kelli
    NEURO-ONCOLOGY, 2023, 25
  • [48] Potential prognostic factors in progression-free survival for patients with cervical cancer
    Chen, Hui-Hui
    Meng, Wei-Yu
    Li, Run-Ze
    Wang, Qing-Yi
    Wang, Yu-Wei
    Pan, Hu-Dan
    Yan, Pei-Yu
    Wu, Qi-Biao
    Liu, Liang
    Yao, Xiao-Jun
    Kang, Min
    Leung, Elaine Lai-Han
    BMC CANCER, 2021, 21 (01)
  • [49] The achievement of a complete molecular response predicts longer progression-free survival in patients with CML treated with imatinib
    Galderisi, C.
    Rempfer, C.
    Mauro, M. J.
    Deininger, M. W.
    Druker, B. J.
    Press, R. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05): : 637 - 637
  • [50] Durvalumab boosts progression-free survival in NSCLC
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2018, 19 (01): : E11 - E11
12345